tiprankstipranks
Trending News
More News >
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Income Statement

Compare
813 Followers

Verona Pharma Income Statement

Last quarter (Q1 2025), Verona Pharma's total revenue was £76.26M, an increase of Infinity% from the same quarter last year. In Q1, Verona Pharma's net income was £-16.32M. See Verona Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 42.28M£ 0.00£ 458.00K£ 40.00M£ 0.00
Gross Profit
£ 39.70M£ -679.62K£ 112.00K£ 40.00M£ -627.85K
Operating Expenses
£ 194.32M£ 67.15M£ 66.23M£ 97.68M£ 66.01M
Depreciation and Amortization
£ 1.06M£ 679.62K£ 636.00K£ 629.00K£ 627.85K
EBITDA
£ -142.19M£ -52.47M£ -67.29M£ -42.19M£ -47.81M
Operating Income
£ -154.63M£ -67.83M£ -66.12M£ -73.31M£ -74.28M
Other Income/Expenses
£ -8.50M£ 12.62M£ 7.30M£ -1.37M£ 6.78M
Pretax Income
£ -163.13M£ -55.21M£ -68.45M£ -55.59M£ -65.00M
Net Income
£ -173.42M£ -54.37M£ -68.70M£ -55.57M£ -65.15M
Per Share Metrics
Basic EPS
£ -2.16£ -0.72£ -1.04£ -0.96£ -2.00
Diluted EPS
£ -2.16£ -0.69£ -1.04£ -0.96£ -2.00
Weighted Average Shares Outstanding
81.54M 75.51M 66.06M 59.15M 32.87M
Weighted Average Shares Outstanding (Diluted)
81.54M 79.27M 66.13M 59.15M 32.87M
Currency in GBP

Verona Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis